English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Meghmani Organics Limited begins commercial production of Cyfluthrin, Spiromesifen in Dahej, Indiaqrcode

Sep. 27, 2022

Favorites Print
Forward
Sep. 27, 2022

DSC08642.JPG


Meghmani Organics Limited (MOL) began the commercial production of Cyfluthrin and Spiromesifen, with initial capacity of 500 MT p.a. for both the products, in Dahej, India.


The production of Cyfluthrin and Spiromesifen are part of the MOLs strategic decision to meet the growing agrochemical demand in domestic and global markets. Going forward, MOL will further announce a series of new chemicals to be manufactured at its plants.  


"With our unique product basket and growing global footprint, backed by prudent capital investments, we are thinking about the future to ensure sustainable long-term growth and create value for our farmers, customers, and the environment," comments MOL.


MOL is one of the leading agrochemical manufacturers with a strong presence in Pan India and global markets. Its agrochemical portfolio includes the intermediates, technicals and formulations of insecticides and herbicides applicable to crop protection, veterinary and public health. 



Click to bookmark and build your agrochemical knowledge base
Print
Forward

0/1200

More from AgroNewsChange

Hot Topic Change

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

Subscribe to daily email alerts of AgroNews.